(VIANEWS) – The NASDAQ ended the session with Pacific Biosciences of California (PACB) jumping 9.26% to $5.61 on Thursday while NASDAQ jumped 2.69% to $12,316.90.

Volume

Today’s last reported volume for Pacific Biosciences of California is 4140090, 37.04% below its average volume of 6576650.

Pacific Biosciences of California’s last close was $5.13, 85.89% under its 52-week high of $36.36.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 17% for the current quarter and 30.3% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 57.1% and a negative 500%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 32.7%, now sitting on 130.51M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pacific Biosciences of California’s stock is considered to be overbought (>=80).

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $5.61 at 20:37 EST, way under its 52-week high of $36.36 and way above its 52-week low of $4.51.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s worth is way below its 50-day moving average of $7.39 and way below its 200-day moving average of $17.48.

More news about Pacific Biosciences of California (PACB).

LEAVE A REPLY

Please enter your comment!
Please enter your name here